TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Pro Medicus Limited ( (AU:PME) ) has provided an announcement.
Pro Medicus Limited has announced a daily update on its ongoing on-market buy-back program, with a total of 3,915 ordinary fully paid securities bought back on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure effectively, potentially enhancing shareholder value and signaling confidence in its financial health.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$320.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, focusing on providing advanced imaging software and services. The company is known for its innovative solutions that cater to the needs of medical professionals and healthcare facilities, enhancing diagnostic capabilities and operational efficiency.
YTD Price Performance: -0.32%
Average Trading Volume: 173,502
Technical Sentiment Signal: Buy
Current Market Cap: A$26.01B
See more insights into PME stock on TipRanks’ Stock Analysis page.